SARA ALHARIRI
Allopathic & Osteopathic Physicians|Internal Medicine EL PASO, TX NPI 1013539667
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX Astellas Pharma US Inc All categories
General Payments — all program years on this page
$373.81
- Category: General Payments
- Program years: PY2023–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $245.01 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $165.02 | 8 |
| Education | $79.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $131.55 | 3 |
| PFIZER INC. | $81.27 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.87 | 1 |
| Acerta Pharma LLC | $13.32 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086776423 | Novartis Pharmaceuticals Corporation | $18.87 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105554244 | AstraZeneca Pharmaceuticals LP | $13.32 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131254003 | PFIZER INC. | $14.65 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131491084 | PFIZER INC. | $24.56 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131790125 | PFIZER INC. | $25.44 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131833240 | PFIZER INC. | $16.62 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139340618 | Astellas Pharma US Inc | $22.91 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139341524 | Astellas Pharma US Inc | $79.99 | 06/21/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1139375149 | Astellas Pharma US Inc | $28.65 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.